INTENSITY THERAPEUTICS, INC. 8-K

What Happened

• Intensity Therapeutics, Inc. (INTS) announced on March 27, 2026 that it released its financial results for the year ended December 31, 2025. The company furnished a press release (attached as Exhibit 99.1 to the Form 8‑K) summarizing those results. The Form 8‑K was signed by CEO Lewis H. Bender.

Key Details

• Filing date: March 27, 2026.
• Reporting period: year ended December 31, 2025.
• Press release furnished as Exhibit 99.1; Cover Page Interactive Data provided as Inline XBRL (Exhibit 104).
• The 8‑K states the press release information is furnished (not “filed”) under Exchange Act Section 18 and includes customary forward‑looking statement caution referencing the company’s Form 10‑K (filed March 27, 2026).

Why It Matters

• For investors, this 8‑K signals the company has publicly disclosed its full‑year 2025 financial results and related commentary; you should read the attached press release and the company’s 2025 Form 10‑K for the detailed numbers, trends in revenue/earnings, and risk disclosures.
• Because the release is furnished (not filed), it is provided for investor information but is subject to different legal incorporation rules under the securities laws.